1. Home
  2. LVRO vs PCRX Comparison

LVRO vs PCRX Comparison

Compare LVRO & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lavoro Limited

LVRO

Lavoro Limited

N/A

Current Price

$0.65

Market Cap

112.6M

Sector

Finance

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.30

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVRO
PCRX
Founded
2017
2006
Country
Brazil
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.6M
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
LVRO
PCRX
Price
$0.65
$26.30
Analyst Decision
Sell
Strong Buy
Analyst Count
3
7
Target Price
$1.88
$32.86
AVG Volume (30 Days)
14.1K
916.7K
Earning Date
02-02-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$1,667,345,189.00
$716,791,000.00
Revenue This Year
N/A
$6.24
Revenue Next Year
$11.45
$9.53
P/E Ratio
N/A
$55.91
Revenue Growth
N/A
3.14
52 Week Low
$0.60
$18.17
52 Week High
$5.60
$27.64

Technical Indicators

Market Signals
Indicator
LVRO
PCRX
Relative Strength Index (RSI) 25.99 64.48
Support Level $0.60 $25.48
Resistance Level $0.69 $27.16
Average True Range (ATR) 0.10 1.00
MACD 0.00 0.15
Stochastic Oscillator 2.70 77.18

Price Performance

Historical Comparison
LVRO
PCRX

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: